Drug Trial Radar · NCT01890837
Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS)
Last checked: Nov 19, 2026Latest source record: Jun 13, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Aug 2013
Primary completion
Mar 2015
Study completion Mar 2015
Sponsor
- Lead sponsor
- Tsumura USAIndustry
- Sponsor type
- Industry
- Collaborators
- Cato Research
- First posted
- Jul 2, 2013
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the effects of 5g of Daikenchuto (TU-100) three times per day (Daikenchuto \[TU-100\] is a botanical agent that modulates gastrointestinal nerves), and placebo on rectal sensation (sensation ratings of urgency to defecate and sensation threshold for pain) in response to rectal balloon distension by barostat in patients with IBS.
Conditions
- Irritable Bowel Syndrome
- Digestive System Diseases
- Gastrointestinal Diseases
- Intestinal Diseases
- Abdominal Pain
Interventions
Daikenchuto (TU-100)Drug
Subjects will receive 5g TID (15g/day) of TU-100. Dosage form is granule. Subject will take a daily dose divided 3 times per day for 2 weeks.
PlaceboDrug
Subjects will receive daily dose of TU-100 placebo. Dosage form is granule. Subject will take a daily dose divided 3 times per day for 2 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sensation rating of urgency to defecate in response to 32 mmHg distension of rectum on a 100 mm VASTime frame: 14 days
- Sensation threshold for pain in response to distention of the rectumTime frame: 14 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Mayo Clinic, Rochester Methodist CRU
Rochester, Minnesota
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.